These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29522388)

  • 1. Alzheimer dementia: Starting, stopping drug therapy.
    Kim LD; Factora RM
    Cleve Clin J Med; 2018 Mar; 85(3):209-214. PubMed ID: 29522388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of problematic behavioral symptoms associated with dementia: a cognitive developmental approach.
    Matteson MA; Linton AD; Cleary BL; Barnes SJ; Lichtenstein MJ
    Aging (Milano); 1997 Oct; 9(5):342-55. PubMed ID: 9458995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between behavioral and psychological symptoms and psychotropic drug use among old people with cognitive impairment living in geriatric care settings.
    Gustafsson M; Sandman PO; Karlsson S; Gustafson Y; Lövheim H
    Int Psychogeriatr; 2013 Sep; 25(9):1415-23. PubMed ID: 23782794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavior as an efficacy outcome.
    Cummings JL
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():v-vi. PubMed ID: 9339265
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease.
    de Oliveira FF; Bertolucci PH; Chen ES; Smith Mde A
    J Neurol Sci; 2014 Jan; 336(1-2):103-8. PubMed ID: 24189208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia.
    Nijk RM; Zuidema SU; Koopmans RT
    Int Psychogeriatr; 2009 Jun; 21(3):485-93. PubMed ID: 19368752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral outcomes in clinical trials for Alzheimer disease.
    Ferris SH; Mackell JA
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():S10-5. PubMed ID: 9339267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in searching for new cognition enhancing drugs.
    Merlini L; Pinza M
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S61-75. PubMed ID: 2694230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic lying to assist people with dementia in maintaining medication adherence.
    Mitchell G
    Nurs Ethics; 2014 Nov; 21(7):844-5. PubMed ID: 25355415
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioral and psychological symptoms of dementia and medical treatment.
    Amano N; Inuzuka S; Ogihara T
    Psychogeriatrics; 2009 Jun; 9(2):45-9. PubMed ID: 19604324
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuropsychiatric symptoms in Alzheimer disease and related disorders: why do treatments work in clinical practice but not in the randomized trials?
    Lavretsky H
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):523-7. PubMed ID: 18591572
    [No Abstract]   [Full Text] [Related]  

  • 12. The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease.
    Bodick NC; Offen WW; Shannon HE; Satterwhite J; Lucas R; van Lier R; Paul SM
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():S16-22. PubMed ID: 9339268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic medication use for behavioral symptoms of dementia.
    Wang PS; Brookhart MA; Setoguchi S; Patrick AR; Schneeweiss S
    Curr Neurol Neurosci Rep; 2006 Nov; 6(6):490-5. PubMed ID: 17074284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Effects of Activities, Social Environment, and Psychotropic Medication Use on Behavioral Symptoms of Individuals With Alzheimer's Disease in Nursing Homes.
    Inventor BR; Farran CJ; Paun O; Cothran F; Rajan K; Swantek SS; McCann JJ
    J Psychosoc Nurs Ment Health Serv; 2018 Nov; 56(11):18-26. PubMed ID: 29741750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamatergic approaches to the treatment of cognitive and behavioural symptoms of Alzheimer's disease.
    Francis PT
    Neurodegener Dis; 2008; 5(3-4):241-3. PubMed ID: 18322401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and psychological symptoms and psychotropic drugs among people with cognitive impairment in nursing homes in 2007 and 2013.
    Gustafsson M; Isaksson U; Karlsson S; Sandman PO; Lövheim H
    Eur J Clin Pharmacol; 2016 Aug; 72(8):987-94. PubMed ID: 27071994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of behavioral and psychological symptoms of dementia and psychotropic drug treatments among old people in geriatric care in 2000 and 2007.
    Lövheim H; Gustafson Y; Karlsson S; Sandman PO
    Int Psychogeriatr; 2011 Dec; 23(10):1616-22. PubMed ID: 21902862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacology and Alzheimer's disease.
    Serby M
    J Adv Med Surg Nurs; 1989 Mar; 1(2):32-9. PubMed ID: 2664071
    [No Abstract]   [Full Text] [Related]  

  • 19. [Challenging pharmacotherapy in dementia].
    Ihl R
    MMW Fortschr Med; 2009 Mar; 151(13):46-8. PubMed ID: 19504818
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
    Ito T; Meguro K; Akanuma K; Meguro M; Lee E; Kasuya M; Ishii H; Mori E
    J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.